1. Home
  2. NYT vs TECH Comparison

NYT vs TECH Comparison

Compare NYT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New York Times Company (The)

NYT

New York Times Company (The)

HOLD

Current Price

$75.76

Market Cap

12.2B

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$72.12

Market Cap

11.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYT
TECH
Founded
1851
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2B
11.2B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
NYT
TECH
Price
$75.76
$72.12
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$72.14
$71.82
AVG Volume (30 Days)
1.4M
3.9M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.16%
0.62%
EPS Growth
18.08
N/A
EPS
0.54
0.81
Revenue
$1,783,639,000.00
$1,219,635,000.00
Revenue This Year
$10.58
$2.49
Revenue Next Year
$6.98
$6.40
P/E Ratio
$138.69
$89.00
Revenue Growth
N/A
5.23
52 Week Low
$53.48
$43.20
52 Week High
$87.10
$72.37

Technical Indicators

Market Signals
Indicator
NYT
TECH
Relative Strength Index (RSI) 53.07 74.99
Support Level $72.59 $70.49
Resistance Level $76.76 N/A
Average True Range (ATR) 2.20 0.33
MACD 0.23 -0.61
Stochastic Oscillator 65.49 80.09

Price Performance

Historical Comparison
NYT
TECH

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: